BioCentury | Apr 8, 2013
Company News

Phosphagenics, Nippon Zoki Pharmaceuticals Co. Ltd. deal

...Following a March 2012 evaluation deal, the companies partnered to develop Phosphagenics' topical TPM/diclofenac to treat...
...last year to allow Nippon to evaluate the product to treat pain. Nippon Zoki markets topical diclofenac...
BioCentury | Mar 12, 2012
Company News

Phosphagenics, Nippon Zoki Pharmaceuticals Co. Ltd. deal

...The companies entered into an agreement to allow Nippon to evaluate Phosphagenics' topical TPM/diclofenac to treat...
BioCentury | Nov 7, 2011
Company News

Phosphagenics, Themis Medicare sales and marketing update

...Phosphagenics granted Themis exclusive rights to TPM/diclofenac in India to treat pain. Under the deal, Themis...
BioCentury | Nov 16, 2009
Company News

Cerimon Pharmaceuticals Inc deal

...An undisclosed party granted Cerimon an exclusive license to develop and commercialize a once-daily topical diclofenac sodium...
BioCentury | Mar 2, 2009
Clinical News

Diclofenac sodium patch: Phase III started

...began a double-blind, placebo-controlled, U.S. and Latin American Phase III trial to evaluate the once-daily, topical diclofenac...
BioCentury | Mar 2, 2009
Clinical News

Diclofenac sodium patch: Phase III started

...Cerimon began a double-blind, placebo-controlled, international Phase III trial to evaluate the once-daily, topical diclofenac sodium patch...
BioCentury | Mar 2, 2009
Clinical News

Diclofenac sodium patch: Phase III started

...began a double-blind, placebo-controlled, U.S. and Latin American Phase III trial to evaluate the once-daily, topical diclofenac...
BioCentury | Nov 17, 2008
Clinical News

Transdermal diclofenac: Phase I started

...Phosphagenics began an open-label, Australian Phase I trial comparing 1% and 2% concentrations of topical diclofenac vs...
BioCentury | Oct 8, 2007
Clinical News

Diclofenac sodium patch: Phase I started

...Cerimon began an open-label, U.S. Phase I trial of topical diclofenac in 16 healthy volunteers. Cerimon Pharmaceuticals...
BioCentury | Feb 24, 2003
Clinical News

Pennsaid topical diclofenac NSAID regulatory update

...also is under review in the U.S. Dimethaid Research Inc. (TSE:DMX), Toronto, Ontario Product: Pennsaid topical diclofenac...
Items per page:
1 - 10 of 35